Department of Dermatology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
Dutch Society of Dermatology and Venereology, Utrecht, the Netherlands.
Br J Dermatol. 2021 Nov;185(5):961-969. doi: 10.1111/bjd.20441. Epub 2021 Jul 5.
Mobile health (mHealth) applications (apps) incorporating artificial intelligence for skin cancer screening are increasingly reimbursed by health insurers. However, an in-depth exploration of the general public's views towards these apps is lacking.
To explore the perceived barriers and facilitators towards mHealth apps for skin cancer screening among the Dutch general population.
A qualitative study consisting of four focus groups with 27 participants was conducted. A two-stage purposive sampling method was used to include information-rich participants from the Dutch general population with varying experience of mHealth. A topic guide was used to structure the sessions. All focus group meetings were transcribed verbatim and analysed in thematic content analysis by two researchers using several coding phases, resulting in an overview of themes and subthemes, categorized as (sub-)barriers and (sub)facilitators.
Main barriers to using mHealth apps included a perceived lack of value, perception of untrustworthiness, preference for a doctor, privacy concerns, a complex user interface, and high costs. The main factors facilitating the use of mHealth among the general population were a high perceived value, a transparent and trustworthy identity of app developers, endorsement by healthcare providers and government regulating bodies, and ease and low costs of use.
To increase successful adoption in skin cancer screening apps, developers should create a transparent identity and build trustworthy apps. Collaboration between app developers, general practitioners and dermatologists is advocated to improve mHealth integration with skin cancer care. Special attention should be given to the development of low-cost, privacy-friendly, easy-to-use apps.
越来越多的医疗保险机构开始报销包含人工智能的移动医疗(mHealth)应用程序(apps)用于皮肤癌筛查。然而,对于普通公众对这些应用程序的看法,我们缺乏深入的探讨。
探索荷兰普通人群对 mHealth 应用程序进行皮肤癌筛查的感知障碍和促进因素。
采用包含 27 名参与者的四个焦点小组的定性研究。使用两阶段的目的性抽样方法,从荷兰普通人群中招募了具有不同 mHealth 经验的信息丰富的参与者。使用主题指南来组织会议。所有焦点小组会议都进行了逐字记录,并由两名研究人员使用多种编码阶段进行主题内容分析,从而得出主题和子主题的概述,分为(子)障碍和(子)促进因素。
使用 mHealth 应用程序的主要障碍包括感知缺乏价值、不信任感、对医生的偏好、隐私问题、复杂的用户界面和高成本。促进普通人群使用 mHealth 的主要因素包括高度感知的价值、应用程序开发者透明和值得信赖的身份、医疗保健提供者和政府监管机构的认可、以及使用的简便和低成本。
为了提高皮肤癌筛查应用程序的成功采用率,开发者应创建透明的身份并构建值得信赖的应用程序。提倡应用程序开发者、全科医生和皮肤科医生之间的合作,以改善 mHealth 与皮肤癌护理的整合。应特别关注开发低成本、保护隐私、易于使用的应用程序。